Browse ADMET evidence entries by endpoint, reported value, assay context, interpretation role, and reference link. These counts indicate evidence availability, not safety, efficacy, or confidence by themselves.
Endpoints
17
·
Context signals
3,678
Measurements
39,523
Interpretation: Record counts indicate evidence availability, not safety, efficacy, or confidence by themselves. Use the ADMET-domain index and role filters to narrow the evidence-entry table before comparing values.
Sandwich ELISARhesus monkeys plasmamonkeyIVSerial blood samples were collected from monkeys that received CP24 or IBP-CP24 before injection and at 2, 4, 6, 24, 72 and 144 h post-injection10 mg/kg
naturalRats plasmaratSCBlood samples (300 μL) were harvested from the tail vein before injection and at different time intervals after injection (0.5, 1.0, 2.0, 4.0, 6.0, 8.0, 10.0 and 24.0 h1.7 μmol/kg
LC-MS/MSGöttingen minipigs plasmaporcineIVBlood samples were collected before RA15127343 administration (baseline) and 1–4 times per day until study end.10 nmol/kg
LC-MSHuman plasma after SC glepaglutide 5 mg after 6 once-weekly doseshumanSC glepaglutide 10 mg after 6 once-weekly dosesblood sampling in subjects receiving 5 and 10 mg of glepaglutide once weekly occurred at the day 1 visit (pre-dose and 0.5, 1, 2, 4, 8, 12, 16, 20, 24, 36, 48, 60, 72, 96 and 120 h post-dose); pre-dose on days 8, 15, 22 and 29; and in connection with the last dosing visit on day 36 (pre-dose and 0.5, 1, 2, 4, 8, 12, 16, 20, 24, 36, 48, 72, 120, 168, 336, 504, 672 and 840 h post-dose)10 mg
